EP2827863
Fljótandi samsetning til notkunar í aðferð við að meðhöndla sjúkdóma sem svara Bendamustínmeðferð hjá sjúklingum sem þurfa að fá minni rúmmál
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.3.2013EP published:
16.1.2019EP application number:
13765020.6
EP translation filed:
8.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
14.3.2033Expiry date:
14.3.2027Next due date:
31.3.2027
Title:
LIQUID COMPOSITION FOR USE IN A METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
Timeline
Today
15.3.2013EP application
16.1.2019EP Publication
8.4.2019Translation submitted
15.5.2019Registration published
14.3.2027Expires
Owner
Name:
Eagle Pharmaceuticals, Inc.Address:
50 Tice Boulevard Suite 315, 07677, Woodcliff Lake, NJ, US
Inventor
Name:
SUNDARAM, SrikanthAddress:
Somerset, New Jersey, US
Name:
TARRIFF, Scott, L.Address:
Mahwah, New Jersey, US
Priority
Number:
201261613173 PDate:
20.3.2012Country:
US
Number:
201261669889 PDate:
10.7.2012Country:
US
Number:
201261678715 PDate:
2.8.2012Country:
US
Classification
Categories:
A61K 31/4184, A61K 47/10, A61K 9/00, A61K 47/02, A61K 47/20
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 2.5.2019
Expires: 14.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 3.3.2020
Expires: 14.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.2.2021
Expires: 14.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.2.2022
Expires: 14.3.2023
Payer: Patice ehf.
Number: 11
Paid: 20.2.2023
Expires: 14.3.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 28.2.2024
Expires: 14.3.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 11.2.2025
Expires: 14.3.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 12.3.2026
Expires: 14.3.2027
Payer: Árnason Faktor ehf.